JOHN MARINO: Open Payments
NPI 1831105899 · CANANDAIGUA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,114 in 144 payments from 14 companies in 2025. Trend: 2023 $17,125 · 2024 $7,423 · 2025 $3,114
Food & beverage: $3,114
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 32 | $560 |
| ABBVIE INC. | 24 | $392 |
| E.R. Squibb & Sons, L.L.C. | 7 | $330 |
| Axsome Therapeutics, Inc. | 17 | $329 |
| Vanda Pharmaceuticals Inc. | 8 | $270 |
| Otsuka America Pharmaceutical, Inc. | 7 | $237 |
| Teva Pharmaceuticals USA, Inc. | 8 | $235 |
| Lundbeck LLC | 11 | $207 |
| Alkermes, Inc. | 6 | $200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $174 |
Products named: CAPLYTA, REXULTI, VRAYLAR, COBENFY, Auvelity, FANAPT, TRINTELLIX, UZEDY.
Industry payments across NY — which companies pay providers there.
